The effect of Chinese herbal medicine Jian Ling Decoction for the treatment of essential hypertension: a systematic review

DSpace/Manakin Repository

The effect of Chinese herbal medicine Jian Ling Decoction for the treatment of essential hypertension: a systematic review

Citable link to this page

 

 
Title: The effect of Chinese herbal medicine Jian Ling Decoction for the treatment of essential hypertension: a systematic review
Author: Xiong, Xingjiang; Wang, Pengqian; Li, Xiaoke; Zhang, Yuqing

Note: Order does not necessarily reflect citation order of authors.

Citation: Xiong, Xingjiang, Pengqian Wang, Xiaoke Li, and Yuqing Zhang. 2015. “The effect of Chinese herbal medicine Jian Ling Decoction for the treatment of essential hypertension: a systematic review.” BMJ Open 5 (2): e006502. doi:10.1136/bmjopen-2014-006502. http://dx.doi.org/10.1136/bmjopen-2014-006502.
Full Text & Related Files:
Abstract: Objectives: Jian Ling Decoction (JLD) is often prescribed to improve hypertension-related symptoms in China. However, this treatment has not been systematically reviewed for its efficacy against essential hypertension (EH). This review aims to assess the current clinical evidence of JLD in the treatment of EH. Design: Seven electronic databases, including the Cochrane Central Register of Controlled Trials, PubMed, EMBASE, the Chinese National Knowledge Infrastructure (CNKI), the Chinese Scientific Journal Database (VIP), the Chinese Biomedical Literature Database (CBM) and the Wanfang Database, were searched up to March 2014. Randomised control trials (RCTs) comparing JLD or combined with antihypertensive drugs versus antihypertensive drugs were included. We assessed the methodological quality, extracted the valid data and conducted the meta-analysis according to criteria from the Cochrane group. The primary outcome was categorical or continuous blood pressure (BP), and the secondary outcome was quality of life (QOL). Results: Ten trials (655 patients) with unclear-to-high risk of bias were identified. Meta-analysis showed that JLD used alone showed no BP reduction effect; however, improvement on QOL was found in the JLD group compared to antihypertensive drugs. A significant reduction in systolic and diastolic BP was observed for JLD plus antihypertensive drugs when compared with antihypertensive drugs alone. No serious adverse effects were reported. Conclusions: Owing to insufficient clinical data, it is difficult to draw a definite conclusion regarding the effectiveness and safety of JLD for EH, and better trials are needed.
Published Version: doi:10.1136/bmjopen-2014-006502
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322192/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:14065537
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters